- call +1-201-465-4211
- email sales@mrinsights.biz
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
Scope of the Report:
The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe.
The global Prostate Cancer Diagnosis and Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prostate Cancer Diagnosis and Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Prostate Cancer Diagnosis and Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prostate Cancer Diagnosis and Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
AbbVie
Active Biotech
Amgen
Astellas Pharma
AstraZeneca
Bavarian Nordic
Bayer
Bristol-Myers Squibb
Dendreon
Endo
Ferring Pharmaceuticals
GE Healthcare
GSK
Ipsen
Johnson & Johnson
Pfizer
Sanofi
Siemens Healthineers
Takeda
Teva Pharmaceutical
Tolmar Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prostate specific antigen test (PSA)
Digital rectal exam (DRE)
Market Segment by Applications, can be divided into
Hospitals
Diagnostic clinics
Research centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Prostate Cancer Diagnosis and Treatment Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnosis and Treatment
1.2 Classification of Prostate Cancer Diagnosis and Treatment by Types
1.2.1 Global Prostate Cancer Diagnosis and Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Types in 2017
1.2.3 Prostate specific antigen test (PSA)
1.2.4 Digital rectal exam (DRE)
1.3 Global Prostate Cancer Diagnosis and Treatment Market by Application
1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Diagnostic clinics
1.3.4 Research centers
1.4 Global Prostate Cancer Diagnosis and Treatment Market by Regions
1.4.1 Global Prostate Cancer Diagnosis and Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Diagnosis and Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Prostate Cancer Diagnosis and Treatment (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Active Biotech
2.3.1 Business Overview
2.3.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Astellas Pharma
2.5.1 Business Overview
2.5.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bavarian Nordic
2.7.1 Business Overview
2.7.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bayer
2.8.1 Business Overview
2.8.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bayer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Dendreon
2.10.1 Business Overview
2.10.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Endo
2.11.1 Business Overview
2.11.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Endo Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Ferring Pharmaceuticals
2.12.1 Business Overview
2.12.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 GE Healthcare
2.13.1 Business Overview
2.13.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.14 GSK
2.14.1 Business Overview
2.14.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GSK Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ipsen
2.15.1 Business Overview
2.15.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.16 Johnson & Johnson
2.16.1 Business Overview
2.16.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.18 Sanofi
2.18.1 Business Overview
2.18.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.19 Siemens Healthineers
2.19.1 Business Overview
2.19.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.20 Takeda
2.20.1 Business Overview
2.20.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Takeda Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.21 Teva Pharmaceutical
2.21.1 Business Overview
2.2.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.22 Tolmar Pharmaceuticals
2.22.1 Business Overview
2.22.2 Prostate Cancer Diagnosis and Treatment Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Prostate Cancer Diagnosis and Treatment Market Competition, by Players
3.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Diagnosis and Treatment Players Market Share
3.2.2 Top 10 Prostate Cancer Diagnosis and Treatment Players Market Share
3.3 Market Competition Trend
4 Global Prostate Cancer Diagnosis and Treatment Market Size by Regions
4.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Regions
4.2 North America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5 North America Prostate Cancer Diagnosis and Treatment Revenue by Countries
5.1 North America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
5.2 USA Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6 Europe Prostate Cancer Diagnosis and Treatment Revenue by Countries
6.1 Europe Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
6.2 Germany Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.4 France Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
7.2 China Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.5 India Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8 South America Prostate Cancer Diagnosis and Treatment Revenue by Countries
8.1 South America Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
8.2 Brazil Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Prostate Cancer Diagnosis and Treatment by Countries
9.1 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Prostate Cancer Diagnosis and Treatment Revenue and Growth Rate (2013-2018)
10 Global Prostate Cancer Diagnosis and Treatment Market Segment by Type
10.1 Global Prostate Cancer Diagnosis and Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Type (2018-2023)
10.3 Prostate specific antigen test (PSA) Revenue Growth Rate (2013-2023)
10.4 Digital rectal exam (DRE) Revenue Growth Rate (2013-2023)
11 Global Prostate Cancer Diagnosis and Treatment Market Segment by Application
11.1 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2013-2018)
11.2 Prostate Cancer Diagnosis and Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostic clinics Revenue Growth (2013-2018)
11.5 Research centers Revenue Growth (2013-2018)
12 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast (2018-2023)
12.1 Global Prostate Cancer Diagnosis and Treatment Market Size Forecast (2018-2023)
12.2 Global Prostate Cancer Diagnosis and Treatment Market Forecast by Regions (2018-2023)
12.3 North America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.6 South America Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Prostate Cancer Diagnosis and Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Prostate Cancer Diagnosis and Treatment Picture
Table Product Specifications of Prostate Cancer Diagnosis and Treatment
Table Global Prostate Cancer Diagnosis and Tr
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
